Fusion Pharma teams up with AstraZeneca in next-gen radiopharmaceuticals for cancer

Fusion Pharmaceuticals (NASDAQ:FUSN) will collaborate with AstraZeneca (NASDAQ:AZN) to develop and commercialize next-generation alpha-emitting radiopharmaceuticals and combination therapies for cancer.